Boston Scientific inks co-promotion deal for Promus Premier stent December 6, 2013 By Chris Walker Leave a Comment Boston Scientific (NYSE:BSX) said it inked a deal with The Medicines Co. to promote its Promus Premier coronary stent in the U.S.